StockData
Aura Biosciences, Inc. logo

Aura Biosciences, Inc. (AURA) stock

AURANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$7.15−0.07 (-0.97%)

Close on Nov 17, 2026Market cap $741.49MP/E –Yield –

Aura Biosciences price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Aura Biosciences's price to book ratio was 2.5× on Nov 11, 2026, against 2.7× a year earlier. Over the last 5 years it ranged from 1.6× to 4.5×, with a median of 2.4×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.5×+0.3
2025Dec 31, 20252.2×−0.2
2024Dec 31, 20242.3×+0.1
2023Dec 29, 20232.2×−0.4
2022Dec 30, 20222.7×–

More Aura Biosciences figures

See a number that looks wrong?